metastatic breast cancer

Showing 26 - 50 of 726

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer Trial in Ocala (Samuraciclib, Fulvestrant)

Recruiting
  • Metastatic Breast Cancer
  • +2 more
  • Ocala, Florida
    Ocala Oncology Center PL DBA Florida Cancer Affiliates
Jul 19, 2023

Triple Negative Breast Cancer, Metastatic Breast Cancer, Mutation Trial in Shanghai (Everolimus, Investigator's Choice of

Not yet recruiting
  • Triple Negative Breast Cancer
  • +2 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jul 25, 2023

Breast Cancer, Metastatic Breast Cancer, HER2-positive Breast Cancer Trial in Amsterdam (89Zr-DFO*-trastuzumab PET scan)

Recruiting
  • Breast Cancer
  • +5 more
  • 89Zr-DFO*-trastuzumab PET scan
  • Amsterdam, Noord-Holland, Netherlands
    AmsterdamUMC
Jul 12, 2023

Metastatic Breast Cancer Trial (BDC-1001, Pertuzumab)

Not yet recruiting
  • Metastatic Breast Cancer
  • (no location specified)
Jul 12, 2023

DESTINY Breast Respond HER2-low Europe

Not yet recruiting
  • Unresectable Breast Cancer
  • +2 more
  • Trastuzumab deruxtecan
  • (no location specified)
Jul 6, 2023

Metastatic Cancer, Metastatic Colorectal Cancer, Metastatic Pancreatic Cancer Trial (OB-002)

Not yet recruiting
  • Metastatic Cancer
  • +5 more
  • (no location specified)
Jul 10, 2023

Metastasis, Metastatic Breast Cancer, Metastatic Prostate Cancer Trial in Spain (To propose a diagnostic test to determine the

Recruiting
  • Metastasis
  • +4 more
  • To propose a diagnostic test to determine the viability of Stereotactic ABlative Radiotherapy (SABR).
  • +2 more
  • Reus, Tarragona, Spain
  • +20 more
Jul 3, 2023

ER+, HER2- Advanced Breast Cancer, Metastatic Breast Cancer Trial in Luoyang, Shanghai (TFX06 tablet)

Recruiting
  • ER+, HER2- Advanced Breast Cancer
  • Metastatic Breast Cancer
  • TFX06 tablet
  • Luoyang, Henan, China
  • +1 more
Jun 25, 2023

Metastatic Breast Cancer Trial in Rome (HER2-D is the use of a non-invasive liquid biopsy method to non-invasively and

Recruiting
  • Metastatic Breast Cancer
  • HER2-D is the use of a non-invasive liquid biopsy method to non-invasively and objectively assess HER2 status at recruitment
  • Rome, Italy
    Fondazione Policlinico A. Gemelli - IRCCS
Jun 22, 2023

Breast Cancer, Metastatic Breast Cancer, Radiation Therapy Complication Trial in Seoul

Recruiting
  • Breast Cancer
  • +2 more
    • Seoul, Korea, Republic of
      Samsung Medical Center
    Jun 8, 2023

    Metastatic Breast Cancer Trial (Olaparib, 17b-estradiol)

    Not yet recruiting
    • Metastatic Breast Cancer
    • (no location specified)
    Jun 2, 2023

    Metastatic Breast Cancer Trial (Inavolisib, Phesgo, Placebo)

    Not yet recruiting
    • Metastatic Breast Cancer
    • (no location specified)
    Jun 7, 2023

    Metastatic Breast Cancer Trial in New York (Tucatinib)

    Recruiting
    • Metastatic Breast Cancer
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    May 26, 2023

    HER2-positive Breast Cancer, Metastatic Cancer, Metastatic Breast Cancer Trial in Chicago, Minneapolis (ALX148, Fam-Trastuzumab

    Recruiting
    • HER2-positive Breast Cancer
    • +17 more
    • ALX148
    • Fam-Trastuzumab Deruxtecan-Nxki
    • Chicago, Illinois
    • +1 more
    May 19, 2023

    Metastatic Breast Cancer, Advanced Non-Small Cell Squamous Lung Cancer, Solid Tumor, Adult Trial (Patritumab deruxtecan)

    Not yet recruiting
    • Metastatic Breast Cancer
    • +2 more
    • Patritumab deruxtecan
    • (no location specified)
    May 9, 2023

    Metastatic Breast Cancer Trial in Italy (Eribulin Mesylate, Capecitabine)

    Active, not recruiting
    • Metastatic Breast Cancer
    • Brescia, Italy
    • +24 more
    Apr 18, 2023

    Breast Cancer, ER-positive Breast Cancer, HER2-negative Breast Cancer Trial in Miami (AI+CDK4/6i, SERD+CDK4/6i, mTOR inhibitor +

    Not yet recruiting
    • Breast Cancer
    • +3 more
    • Miami, Florida
      University of Miami
    Apr 12, 2023

    Metastatic Breast Cancer Trial in Seoul (Fulvestrant plus AI plus ribociclib, AI plus ribociclib)

    Not yet recruiting
    • Metastatic Breast Cancer
    • Fulvestrant plus AI plus ribociclib
    • AI plus ribociclib
    • Seoul, Korea, Republic of
      Korea university Guro hospital
    Apr 16, 2023

    Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer Trial (MEN1611, Eribulin)

    Not yet recruiting
    • Breast Cancer
    • +2 more
    • (no location specified)
    Apr 12, 2023

    Using a Blood Test to Monitor Metastatic Breast Cancer Treatment

    Not yet recruiting
    • Metastatic Breast Cancer
      • Kingston, Ontario, Canada
      • +1 more
      Mar 27, 2023

      Prostate Cancer, Breast Cancer, Kidney Cancer Trial in Tampere (behavioral, drug, other)

      Not yet recruiting
      • Prostate Cancer
      • +11 more
      • Guided physical exercise
      • +2 more
      • Tampere, Länsi-Suomi, Finland
        Tampere University Hospital
      Apr 3, 2023

      Metastatic Breast Cancer Trial in Kansas City, Rochester, Saint Louis (ATI-2231, Capecitabine, Denosumab)

      Not yet recruiting
      • Metastatic Breast Cancer
      • Kansas City, Kansas
      • +2 more
      Mar 16, 2023

      Metastatic Breast Cancer Trial in Zhengzhou (SHR-A1811, Pyrotinib, Bevacizumab)

      Not yet recruiting
      • Metastatic Breast Cancer
      • Zhengzhou, Henan, China
        Henan Cancer Hospital
      Mar 13, 2023

      Metastatic Breast Cancer, Metastatic Gastric Cancer Trial in Changchun (Trastuzumab for injection, Herceptin)

      Completed
      • Metastatic Breast Cancer
      • Metastatic Gastric Cancer
      • Changchun, Jilin, China
        Affiliated Hospital of Changchun University of Traditional Chine
      Mar 1, 2023